These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 27098123)

  • 21. Isochlorogenic Acid C Reverses Epithelial-Mesenchymal Transition
    Yu JK; Yue CH; Pan YR; Chiu YW; Liu JY; Lin KI; Lee CJ
    Anticancer Res; 2018 Apr; 38(4):2127-2135. PubMed ID: 29599331
    [TBL] [Abstract][Full Text] [Related]  

  • 22. S100A4 promotes endometrial cancer progress through epithelial-mesenchymal transition regulation.
    Hua T; Liu S; Xin X; Cai L; Shi R; Chi S; Feng D; Wang H
    Oncol Rep; 2016 Jun; 35(6):3419-26. PubMed ID: 27109209
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inversed Expression Patterns of S100A4 and E-Cadherin in Cervical Cancers: Implication in Epithelial-Mesenchymal Transition.
    Liu M; Liu J; Yang B; Gao X; Gao LL; Kong QY; Zhang P; Li H
    Anat Rec (Hoboken); 2017 Dec; 300(12):2184-2191. PubMed ID: 28921916
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cyr61/CCN1 overexpression induces epithelial-mesenchymal transition leading to laryngeal tumor invasion and metastasis and poor prognosis.
    Liu Y; Zhou YD; Xiao YL; Li MH; Wang Y; Kan X; Li QY; Lu JG; Jin DJ
    Asian Pac J Cancer Prev; 2015; 16(7):2659-64. PubMed ID: 25854342
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of Increased Invasiveness of Breast Cancer Cells With Acquired Tamoxifen Resistance by Suppression of CYR61.
    Bauerschmitz G; Hüchel S; Gallwas J; Gründker C
    Cancer Genomics Proteomics; 2023; 20(6):531-538. PubMed ID: 37889058
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pro-metastatic functions of Notch signaling is mediated by CYR61 in breast cells.
    Ilhan M; Kucukkose C; Efe E; Gunyuz ZE; Firatligil B; Dogan H; Ozuysal M; Yalcin-Ozuysal O
    Eur J Cell Biol; 2020 Apr; 99(2-3):151070. PubMed ID: 32005345
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel anti-Cyr61 antibody inhibits breast cancer growth and metastasis in vivo.
    Lin J; Huo R; Wang L; Zhou Z; Sun Y; Shen B; Wang R; Li N
    Cancer Immunol Immunother; 2012 May; 61(5):677-87. PubMed ID: 22048717
    [TBL] [Abstract][Full Text] [Related]  

  • 28. miR-187-3p inhibits the metastasis and epithelial-mesenchymal transition of hepatocellular carcinoma by targeting S100A4.
    Dou C; Liu Z; Xu M; Jia Y; Wang Y; Li Q; Yang W; Zheng X; Tu K; Liu Q
    Cancer Lett; 2016 Oct; 381(2):380-90. PubMed ID: 27544906
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Integrin (alpha6beta4) signals through Src to increase expression of S100A4, a metastasis-promoting factor: implications for cancer cell invasion.
    Kim TH; Kim HI; Soung YH; Shaw LA; Chung J
    Mol Cancer Res; 2009 Oct; 7(10):1605-12. PubMed ID: 19808905
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Agonists and antagonists of GnRH-I and -II reduce metastasis formation by triple-negative human breast cancer cells in vivo.
    Schubert A; Hawighorst T; Emons G; Gründker C
    Breast Cancer Res Treat; 2011 Dec; 130(3):783-90. PubMed ID: 21279682
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Estrogen receptor beta as epigenetic mediator of miR-10b and miR-145 in mammary cancer.
    Piperigkou Z; Franchi M; Götte M; Karamanos NK
    Matrix Biol; 2017 Dec; 64():94-111. PubMed ID: 28797712
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Failure to detect gonadotrophin-releasing hormone receptors in human benign and malignant breast tissue and in MCF-7 and MDA-MB-231 cancer cells.
    Mullen P; Bramley T; Menzies G; Miller B
    Eur J Cancer; 1993; 29A(2):248-52. PubMed ID: 8380699
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression and regulation of Cyr61 in human breast cancer cell lines.
    Tsai MS; Bogart DF; Li P; Mehmi I; Lupu R
    Oncogene; 2002 Jan; 21(6):964-73. PubMed ID: 11840342
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cyr61 promotes epithelial-mesenchymal transition and tumor metastasis of osteosarcoma by Raf-1/MEK/ERK/Elk-1/TWIST-1 signaling pathway.
    Hou CH; Lin FL; Hou SM; Liu JF
    Mol Cancer; 2014 Oct; 13():236. PubMed ID: 25326651
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Notch1 signaling regulates the epithelial-mesenchymal transition and invasion of breast cancer in a Slug-dependent manner.
    Shao S; Zhao X; Zhang X; Luo M; Zuo X; Huang S; Wang Y; Gu S; Zhao X
    Mol Cancer; 2015 Feb; 14(1):28. PubMed ID: 25645291
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CYR61 triggers osteosarcoma metastatic spreading via an IGF1Rβ-dependent EMT-like process.
    Habel N; Stefanovska B; Carène D; Patiño-Garcia A; Lecanda F; Fromigué O
    BMC Cancer; 2019 Jan; 19(1):62. PubMed ID: 30642298
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Osterix promotes the migration and angiogenesis of breast cancer by upregulation of S100A4 expression.
    Qu S; Wu J; Bao Q; Yao B; Duan R; Chen X; Li L; Yuan H; Jin Y; Ma C
    J Cell Mol Med; 2019 Feb; 23(2):1116-1127. PubMed ID: 30450809
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PPARγ agonist rosiglitazone inhibits migration and invasion by downregulating Cyr61 in rheumatoid arthritis fibroblast-like synoviocytes.
    Kwon EJ; Park EJ; Choi S; Kim SR; Cho M; Kim J
    Int J Rheum Dis; 2017 Oct; 20(10):1499-1509. PubMed ID: 27456070
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Livin promotes progression of breast cancer through induction of epithelial-mesenchymal transition and activation of AKT signaling.
    Li F; Yin X; Luo X; Li HY; Su X; Wang XY; Chen L; Zheng K; Ren GS
    Cell Signal; 2013 Jun; 25(6):1413-22. PubMed ID: 23524337
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CRH suppressed TGFβ1-induced Epithelial-Mesenchymal Transition via induction of E-cadherin in breast cancer cells.
    Jin L; Chen J; Li L; Li C; Chen C; Li S
    Cell Signal; 2014 Apr; 26(4):757-65. PubMed ID: 24412750
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.